These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Liposclerosing myxofibrous tumor (LSMFT), a study of 33 patients: should it be a distinct entity? Dattilo J, McCarthy EF. Iowa Orthop J; 2012; 32():35-9. PubMed ID: 23576919 [Abstract] [Full Text] [Related]
4. [Bone liposclerosing myxofibrous tumor. Case presentation and literature review]. Técualt-Gómez R, Atencio-Chan A, Cario-Méndez AG, Amaya-Zepeda RA, Balderas-Martinez J, González-Valladares JR. Acta Ortop Mex; 2015; 29(3):191-5. PubMed ID: 26999973 [Abstract] [Full Text] [Related]
5. Liposclerosing myxofibrous tumour: a traumatized variant of fibrous dysplasia? Report of four cases and review of the literature. Heim-Hall JM, Williams RP. Histopathology; 2004 Oct; 45(4):369-76. PubMed ID: 15469475 [Abstract] [Full Text] [Related]
7. Liposclerosing myxofibrous tumor of the distal femur: A case report. Zhang M, Zhang D, Yu W, Wang C. Front Surg; 2022 Oct; 9():1009975. PubMed ID: 36684277 [Abstract] [Full Text] [Related]
17. Bone abnormal signal incidentally found in pre-biopsy diffusion-weighted MRI for suspected prostate cancer: what does it reflect? Yachida Y, Yoshida S, Takeshita H, Sawamura C, Tanaka H, Satoh S, Uchida Y, Ishioka J, Matsuoka Y, Numao N, Koga F, Saito K, Fujii Y, Kihara K. Urol Int; 2014 Jan; 93(2):170-5. PubMed ID: 24732031 [Abstract] [Full Text] [Related]